These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2861523)

  • 1. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.
    Baumgartner JD; Glauser MP; McCutchan JA; Ziegler EJ; van Melle G; Klauber MR; Vogt M; Muehlen E; Luethy R; Chiolero R
    Lancet; 1985 Jul; 2(8446):59-63. PubMed ID: 2861523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-endotoxin core glycolipid antibody: the preparation of immune serum of E. Coli J5].
    Xu XN; Li ZJ; Li YP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):358-60. PubMed ID: 15182450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.
    Calandra T; Glauser MP; Schellekens J; Verhoef J
    J Infect Dis; 1988 Aug; 158(2):312-9. PubMed ID: 3136210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.
    Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI
    N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
    Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
    N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ineffectiveness of single-dose human antiserum to core glycolipid (E. coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutropenia.
    McCutchan JA; Wolf JL; Ziegler EJ; Braude AI
    Schweiz Med Wochenschr Suppl; 1983; 14():40-5. PubMed ID: 6361990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprophylaxis and immunotherapy of Gram-negative infections in the immunocompromised host.
    Glauser MP; McCutchan JA; Ziegler E
    Clin Haematol; 1984 Oct; 13(3):549-55. PubMed ID: 6388931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
    Greenman RL; Schein RM; Martin MA; Wenzel RP; MacIntyre NR; Emmanuel G; Chmel H; Kohler RB; McCarthy M; Plouffe J
    JAMA; 1991 Aug; 266(8):1097-102. PubMed ID: 1865542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing death from shock by antibody to endotoxin core glycolipid.
    Lancet; 1985 Sep; 2(8454):565-6. PubMed ID: 2863593
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to endotoxin in the treatment of gram-negative sepsis.
    McCabe WR
    JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 14. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
    Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
    J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin-polymyxin complexes in an improved enzyme-linked immunosorbent assay for IgG antibodies in blood donor sera to gram-negative endotoxin core glycolipids.
    Scott BB; Barclay GR
    Vox Sang; 1987; 52(4):272-80. PubMed ID: 2820153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to Escherichia coli J5 core glycolipids in gnotobiotic and conventionally reared piglets.
    McVey DS; Anderson NV
    Vet Microbiol; 1989 Mar; 19(3):283-9. PubMed ID: 2655265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
    Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
    Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial endotoxins and their effects].
    Bertók L
    Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody to endotoxin in the treatment of gram-negative sepsis.
    van Deventer S
    JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.